Skip to main content
TipRanks
Go Ultimate75% OFF

MetaVia (MTVA) Stock Price & Analysis

506 Followers

MTVA Stock Chart & Stats

$1.30$0.00(0.00%)
At close: 4:00 PM EST
$1.25$1.5$1.75Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$1.25 - $1.43
52-Week Range
$0.97 - $13.42
Previous Close
$1.30
Volume
N/A
Average Volume (3M)
149.35K
Market Cap
$8.56M
Enterprise Value
$1.87M
Total Cash (Recent Filing)
$8.78M
Total Debt (Recent Filing)
$160.00K
Price to Earnings (P/E)
―
Beta
1.35
Next Earnings
Apr 01, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Promising Phase 1 Efficacy

DA-1726 has generated clinically relevant early efficacy signals across liver fat and body weight, supporting its potential fit in liver-related cardiometabolic disease. If replicated in larger and longer studies, these results could strengthen the pipeline’s development rationale and partnering appeal.

Differentiated Preclinical Profile

The head-to-head study suggests DA-1726 may achieve weight loss through a differentiated metabolic mechanism involving glucagon-associated energy expenditure, FGF21 and thermogenesis. These findings could help distinguish the candidate scientifically, although clinical validation remains necessary.

Low Financial Leverage

Very low leverage reduces near-term solvency pressure and limits the burden of mandatory debt service while the company advances its clinical pipeline. This conservative capital structure provides more flexibility than a heavily indebted balance sheet, even though equity resources are declining.

Bears Say

Pre-revenue Operating Model

MTVA has no commercial revenue base to fund research, development or corporate costs, leaving value dependent on successful clinical execution and eventual commercialization. Persistent losses also mean the company cannot yet demonstrate a self-sustaining operating model or durable earnings power.

Sustained Cash Burn

Ongoing negative operating and free cash flow shows that current activities consume capital rather than generate internal funding. Continued development spending without revenue increases the likelihood that MTVA will need additional financing, making funding availability an important execution constraint.

Shrinking Equity Cushion

The sharp reduction in shareholders’ equity indicates that losses are depleting the company’s capital base despite low debt. A thinner equity cushion reduces financial resilience and can increase reliance on future capital raising, potentially constraining strategy and creating dilution risk.

MetaVia News

MTVA FAQ

What was MetaVia’s price range in the past 12 months?
MetaVia lowest stock price was $0.97 and its highest was $13.42 in the past 12 months.
What is MetaVia’s market cap?
MetaVia’s market cap is $8.56M.
When is MetaVia’s upcoming earnings report date?
MetaVia’s next earnings report is estimated for Apr 01, 2027 (not yet confirmed), which is in 135 days.
How were MetaVia’s earnings last quarter?
MetaVia released its earnings results on Nov 13, 2026. The company reported -$0.69 earnings per share for the quarter, beating the consensus estimate of -$0.733 by $0.043.
Is MetaVia overvalued?
According to Wall Street analysts MetaVia’s price is currently Undervalued.
Does MetaVia pay dividends?
MetaVia does not currently pay dividends.
What is MetaVia’s EPS estimate?
MetaVia’s EPS estimate is -0.64.
How many shares outstanding does MetaVia have?
MetaVia has 6,588,101 shares outstanding.
What happened to MetaVia’s price movement after its last earnings report?
MetaVia reported an EPS of -$0.69 in its last earnings report, beating expectations of -$0.733. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MetaVia?
Hedge funds hold MetaVia shares: the largest hedge-fund position in MetaVia is 71,887,924 shares, and hedge funds decreased their holdings by 472.0 shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology